1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 4: 
Angiographic and clinical outcome by site of vascular occlusion
UK (n = 72)RT (n = 125)P Value
ICA occlusions
    Final TICI ≥2b13 (59.1)32 (64.0).86
    Discharge mRS, 0–35 (22.7)12 (24).98
M1 occlusions
    Final TICI ≥2b16 (50.0)28 (62.2).23
    Discharge mRS, 0–312 (37.5)21 (46.6).37
M2 occlusions
    Final TICI ≥2b10 (55.5)16 (53.3).85
    Discharge mRS, 0–310 (55.5)13 (43.3).46
  • 

    Note:—Values in parentheses are percentages.